For instance, human glioma and leukaemia CSCs express lower levels of Fas and Fas ligand (Fas-L) resulting in resistance to extrinsic receptor-mediated cell death [72,73,74,75,76,77]. The gene discussed is FASLG; the disease is central nervous system cancer.